Zobrazeno 1 - 10
of 508
pro vyhledávání: '"CT Dollery"'
Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress
Autor:
C Nachev, P. W. De Leeuw, Lutgarde Thijs, Y Yodfat, A E Fletcher, Christopher J. Bulpitt, M. Safar, K Kawecka-Jaszcz, J Webster, Robert Fagard, J Rosenfeld, GG Arabidze, Hilde Celis, Jan A. Staessen, J Duggan, J Tuomilehto, Jerzy Gasowski, W. H. Birkenhäger, JL Rodicio, M.-L. Seux, CT Dollery, G Leonetti
Publikováno v:
Journal of Human Hypertension. 13:135-145
The Systolic Hypertension in Europe (Syst-Eur) trial proved that blood pressure (BP) lowering therapy starting with nitrendipine reduces the risk of cardiovascular complications in older (> or = 60 years) patients with isolated systolic hypertension
Autor:
CT Dollery
Publikováno v:
British Journal of Clinical Pharmacology. 13:127-132
Publikováno v:
British Journal of Clinical Pharmacology. 13:847-854
1 Methyldopa has a short plasma half-life, but longer duration of antihypertensive effect. A single bedtime dose of methyldopa has been recommended to improve compliance and decrease side effects. 2 This double-blind crossover study was designed to d
Autor:
DS Davies, CT Dollery
Publikováno v:
British Journal of Clinical Pharmacology. 10:5S-12S
1 The brain plays an important role in the regulation of blood pressure. Noradrenaline-containing cell bodies are present in several areas of the medulla. The nucleus of the solitary tract, an important centre for regulating baroreceptor and chemorec
Autor:
CT Dollery, JC Mucklow
Publikováno v:
British Journal of Clinical Pharmacology. 6:75-79
1 Seizure control, saliva anticonvulsant concentration, prescribing habits and compliance with anticonvulsant medication have been compared in 86 epileptic subjects attending either a specialist hospital clinic or general practice surgeries. 2 Of all
Autor:
CT Dollery, MJ Brown
Publikováno v:
British Journal of Clinical Pharmacology. 11:79-83
1 A sensitive radioenzymatic assay was developed, in which DOPA is enzymatically decarboxylated to dopamine and the latter converted to [3H]-methoxytyramine in the presence of [3H]-S-adenosyl-L-methionine and catechol-o-methyltransferase. 2 The assay
1. Seven atopic subjects received two injections of antigen and one of saline intradermally in the back on each of 4 separate days. They were pretreated with four different drug combinations: (a) adrenaline 0.3 mg subcutaneously over the deltoid musc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ac45ada2a11873d30846a663a71ca9
https://europepmc.org/articles/PMC1379777/
https://europepmc.org/articles/PMC1379777/
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d29918b333f8c7efd82be9772c72c9e0
http://europepmc.org/abstract/med/5085361
http://europepmc.org/abstract/med/5085361
Publikováno v:
Europe PubMed Central
The effects of pentolinium tartrate 2.5 mg i.v. on blood pressure, heart rate and plasma noradrenaline and adrenaline concentrations were studied in 21 hypertensives and in 20 normal controls. Mean basal catecholamine concentrations and the extent of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3a78864080e5a581ed616ceaac8d1cdd
http://europepmc.org/abstract/med/6678820
http://europepmc.org/abstract/med/6678820
Autor:
CT Dollery
Publikováno v:
British Journal of Clinical Pharmacology. 6:379-376